JOHN B HENNEMAN III Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for JOHN B HENNEMAN III.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of JOHN B HENNEMAN III. JOHN B HENNEMAN III is Director in Anika Therapeutics, Inc. ($ANIK) and Chief Administrative Officer in NEWLINK GENETICS CORP ($NLNK) and EVP, Chief Financial Officer in NEWLINK GENETICS CORP ($NLNK) and Director in Accretive Health, Inc. ($AH) and Director in SeaSpine Holdings Corp ($SPNE) and in Aprea Therapeutics, Inc. ($APRE).

Latest Insider Trading Transactions of JOHN B HENNEMAN III

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ANIK, APRE, NLNK, AH, SPNE

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 04 2021	SPNE	SeaSpine Holdings ...	HENNEMAN JOHN B III	Director	Grant	A	0.00	6,253	0	66,711	60.5 K to 66.7 K (+10.34 %)
May 24 2021	AH	R1 RCM INC.	HENNEMAN JOHN B III	Director	Option Exercise	A	0.00	5,151	0	5,151
Apr 02 2021	AH	R1 RCM INC.	HENNEMAN JOHN B III	Director	Option Exercise	A	24.98	1,490	37,220	1,490
Jan 05 2021	AH	R1 RCM INC.	HENNEMAN JOHN B III	Director	Option Exercise	A	23.49	1,625	38,171	1,625
Oct 02 2020	AH	R1 RCM INC.	HENNEMAN JOHN B III	Director	Option Exercise	A	17.54	2,186	38,342	2,186
Sep 08 2020	ANIK	Anika Therapeutics ...	HENNEMAN JOHN B III	Director	Grant	A	0.00	9,310	0	9,310	0 to 9.3 K
Aug 05 2020	SPNE	SeaSpine Holdings ...	HENNEMAN JOHN B III	Director	Sell	S	15.00	10,000	150,000	60,458	70.5 K to 60.5 K (-14.19 %)
Jul 02 2020	AH	R1 RCM INC.	HENNEMAN JOHN B III	Director	Option Exercise	A	11.78	3,249	38,273	3,249
Jul 01 2020	APRE	Aprea Therapeutics ...	HENNEMAN JOHN B III		Option Exercise	A	38.78	5,600	217,168	5,600
Jun 05 2020	SPNE	SeaSpine Holdings ...	HENNEMAN JOHN B III	Director	Grant	A	0.00	8,488	0	70,458	62 K to 70.5 K (+13.70 %)
Apr 03 2020	AH	R1 RCM INC.	HENNEMAN JOHN B III	Director	Option Exercise	A	8.41	4,542	38,198	4,542
Apr 03 2020	AH	R1 RCM INC.	HENNEMAN JOHN B III	Director	Option Exercise	A	8.41	4,542	38,198	4,542
Jan 03 2020	AH	R1 RCM INC.	HENNEMAN JOHN B III	Director	Option Exercise	A	12.69	2,851	36,179	2,851
Jan 03 2020	AH	R1 RCM INC.	HENNEMAN JOHN B III	Director	Option Exercise	A	12.69	2,851	36,179	2,851
Oct 07 2019	APRE	Aprea Therapeutics ...	HENNEMAN JOHN B III		Option Exercise	A	15.00	18,407	276,105	18,407
Oct 07 2019	APRE	Aprea Therapeutics ...	HENNEMAN JOHN B III		Option Exercise	A	15.00	18,407	276,105	18,407
Oct 07 2019	APRE	Aprea Therapeutics ...	HENNEMAN JOHN B III		Buy	P	15.00	5,000	75,000	5,000	0 to 5 K
Oct 07 2019	APRE	Aprea Therapeutics ...	HENNEMAN JOHN B III		Buy	P	15.00	5,000	75,000	5,000	0 to 5 K
Oct 03 2019	AH	R1 RCM INC.	HENNEMAN JOHN B III	Director	Option Exercise	A	9.05	4,025	36,426	4,025
Jul 02 2019	AH	R1 RCM INC.	HENNEMAN JOHN B III	Director	Option Exercise	A	12.65	2,846	36,002	2,846
Apr 02 2019	AH	R1 RCM INC.	HENNEMAN JOHN B III	Director	Option Exercise	A	9.57	3,684	35,256	3,684
Jan 03 2019	AH	R1 RCM INC.	HENNEMAN JOHN B III	Director	Option Exercise	A	7.89	4,285	33,809	4,285
Oct 03 2018	AH	R1 RCM INC.	HENNEMAN JOHN B III	Director	Option Exercise	A	10.01	3,319	33,223	3,319
Oct 02 2018	NLNK	NEWLINK GENETICS C ...	HENNEMAN JOHN B III	Chief Administrativ ...	Payment of Exercise	F	2.28	2,484	5,664	55,052	57.5 K to 55.1 K (-4.32 %)
Aug 29 2018	SPNE	SeaSpine Holdings ...	HENNEMAN JOHN B III	Director	Sell	S	14.65	3,407	49,913	54,708	58.1 K to 54.7 K (-5.86 %)
Aug 29 2018	SPNE	SeaSpine Holdings ...	HENNEMAN JOHN B III	Director	Sell	S	14.65	2,029	29,725	58,115	60.1 K to 58.1 K (-3.37 %)
Aug 29 2018	SPNE	SeaSpine Holdings ...	HENNEMAN JOHN B III	Director	Sell	S	14.72	4,564	67,182	60,144	64.7 K to 60.1 K (-7.05 %)
Jun 13 2018	SPNE	SeaSpine Holdings ...	HENNEMAN JOHN B III	Director	Option Exercise	M	12.44	17,398	216,431	0
Jun 13 2018	SPNE	SeaSpine Holdings ...	HENNEMAN JOHN B III	Director	Buy	M	12.44	17,398	216,431	64,708	47.3 K to 64.7 K (+36.77 %)
May 31 2018	SPNE	SeaSpine Holdings ...	HENNEMAN JOHN B III	Director	Grant	A	0.00	4,429	0	47,310	42.9 K to 47.3 K (+10.33 %)
May 31 2018	SPNE	SeaSpine Holdings ...	HENNEMAN JOHN B III	Director	Grant	A	0.00	4,429	0	47,310	42.9 K to 47.3 K (+10.33 %)
May 31 2018	SPNE	SeaSpine Holdings ...	HENNEMAN JOHN B III	Director	Grant	A	0.00	8,857	0	42,881	34 K to 42.9 K (+26.03 %)
May 31 2018	SPNE	SeaSpine Holdings ...	HENNEMAN JOHN B III	Director	Grant	A	0.00	8,857	0	42,881	34 K to 42.9 K (+26.03 %)
Apr 03 2018	AH	R1 RCM INC.	HENNEMAN JOHN B III	Director	Option Exercise	A	7.07	4,770	33,724	4,770
Mar 13 2018	NLNK	NEWLINK GENETICS C ...	HENNEMAN JOHN B III	EVP, Chief Financia ...	Option Exercise	A	7.85	122,000	957,700	122,000
Jan 04 2018	NLNK	NEWLINK GENETICS C ...	HENNEMAN JOHN B III	EVP, Chief Financia ...	Payment of Exercise	F	10.06	1,323	13,309	57,536	58.9 K to 57.5 K (-2.25 %)
Jan 04 2018	NLNK	NEWLINK GENETICS C ...	HENNEMAN JOHN B III	EVP, Chief Financia ...	Payment of Exercise	F	8.47	164	1,389	58,859	59 K to 58.9 K (-0.28 %)
Oct 03 2017	AH	R1 RCM INC.	HENNEMAN JOHN B III	Director	Option Exercise	A	3.76	9,169	34,475	9,169
Oct 02 2017	NLNK	NEWLINK GENETICS C ...	HENNEMAN JOHN B III	EVP, Chief Financia ...	Payment of Exercise	F	10.18	2,789	28,392	56,544	59.3 K to 56.5 K (-4.70 %)
Jun 15 2017	SPNE	SeaSpine Holdings ...	HENNEMAN JOHN B III	Director	Grant	A	0.00	15,121	0	34,024	18.9 K to 34 K (+79.99 %)
Apr 05 2017	AH	R1 RCM INC.	HENNEMAN JOHN B III	Director	Option Exercise	A	3.08	10,512	32,377	10,512
Jan 05 2017	NLNK	NEWLINK GENETICS C ...	HENNEMAN JOHN B III	EVP, Chief Financia ...	Option Exercise	A	10.55	137,500	1,450,625	137,500
Jan 05 2017	NLNK	NEWLINK GENETICS C ...	HENNEMAN JOHN B III	EVP, Chief Financia ...	Payment of Exercise	F	11.04	1,323	14,606	58,612	59.9 K to 58.6 K (-2.21 %)
Jan 05 2017	NLNK	NEWLINK GENETICS C ...	HENNEMAN JOHN B III	EVP, Chief Financia ...	Payment of Exercise	F	10.28	164	1,686	59,935	60.1 K to 59.9 K (-0.27 %)
Jan 04 2017	AH	Accretive Health, ...	HENNEMAN JOHN B III	Director	Option Exercise	A	2.29	14,098	32,284	14,098
Oct 05 2016	AH	Accretive Health, ...	HENNEMAN JOHN B III	Director	Option Exercise	A	2.42	13,762	33,304	13,762
Oct 04 2016	NLNK	NEWLINK GENETICS C ...	HENNEMAN JOHN B III	EVP, Chief Financia ...	Payment of Exercise	F	15.02	2,789	41,891	60,099	62.9 K to 60.1 K (-4.43 %)
Aug 17 2016	AH	Accretive Health, ...	HENNEMAN JOHN B III	Director	Buy	P	1.80	12,500	22,500	50,000	37.5 K to 50 K (+33.33 %)
Aug 17 2016	AH	Accretive Health, ...	HENNEMAN JOHN B III	Director	Buy	P	1.80	1,500	2,700	37,500	36 K to 37.5 K (+4.17 %)
Aug 17 2016	AH	Accretive Health, ...	HENNEMAN JOHN B III	Director	Buy	P	1.81	14,500	26,245	36,000	21.5 K to 36 K (+67.44 %)
Aug 17 2016	AH	Accretive Health, ...	HENNEMAN JOHN B III	Director	Buy	P	1.81	1,500	2,715	21,500	20 K to 21.5 K (+7.50 %)
Aug 17 2016	AH	Accretive Health, ...	HENNEMAN JOHN B III	Director	Buy	P	1.80	10,000	17,975	20,000	10 K to 20 K (+100.00 %)
Aug 17 2016	AH	Accretive Health, ...	HENNEMAN JOHN B III	Director	Buy	P	1.80	7,800	14,040	10,000	2.2 K to 10 K (+354.55 %)
Aug 17 2016	AH	Accretive Health, ...	HENNEMAN JOHN B III	Director	Buy	P	1.79	500	895	2,200	1.7 K to 2.2 K (+29.41 %)
Aug 17 2016	AH	Accretive Health, ...	HENNEMAN JOHN B III	Director	Buy	P	1.77	500	885	1,700	1.2 K to 1.7 K (+41.67 %)
Aug 17 2016	AH	Accretive Health, ...	HENNEMAN JOHN B III	Director	Buy	P	1.79	500	893	1,200	700 to 1.2 K (+71.43 %)
Aug 17 2016	AH	Accretive Health, ...	HENNEMAN JOHN B III	Director	Buy	P	1.77	100	177	700	600 to 700 (+16.67 %)
Aug 17 2016	AH	Accretive Health, ...	HENNEMAN JOHN B III	Director	Buy	P	1.79	500	895	600	100 to 600 (+500.00 %)
Aug 17 2016	AH	Accretive Health, ...	HENNEMAN JOHN B III	Director	Buy	P	1.78	100	178	100	0 to 100
Aug 11 2016	NLNK	NEWLINK GENETICS C ...	HENNEMAN JOHN B III	EVP, Chief Financia ...	Option Exercise	A	10.78	150,000	1,617,000	150,000
Jul 06 2016	AH	Accretive Health, ...	HENNEMAN JOHN B III	Director	Option Exercise	A	2.00	15,385	30,770	15,385
Jun 09 2016	SPNE	SeaSpine Holdings ...	HENNEMAN JOHN B III	Director	Option Exercise	A	9.99	13,920	139,061	13,920
Jun 09 2016	SPNE	SeaSpine Holdings ...	HENNEMAN JOHN B III	Director	Grant	A	0.00	10,010	0	18,903	8.9 K to 18.9 K (+112.56 %)
Apr 05 2016	AH	Accretive Health, ...	HENNEMAN JOHN B III	Director	Option Exercise	A	2.53	12,048	30,481	12,048
Feb 24 2016	AH	Accretive Health, ...	HENNEMAN JOHN B III	Director	Option Exercise	A	2.61	405,111	1,057,340	405,111
Jan 06 2016	NLNK	NEWLINK GENETICS C ...	HENNEMAN JOHN B III	EVP, Chief Financia ...	Option Exercise	A	34.73	46,351	1,609,770	46,351
Jan 06 2016	NLNK	NEWLINK GENETICS C ...	HENNEMAN JOHN B III	EVP, Chief Financia ...	Sell	S	35.74	175	6,255	62,316	62.5 K to 62.3 K (-0.28 %)
Jan 06 2016	NLNK	NEWLINK GENETICS C ...	HENNEMAN JOHN B III	EVP, Chief Financia ...	Grant	A	0.00	16,201	0	62,491	46.3 K to 62.5 K (+35.00 %)
Jan 05 2016	SPNE	SeaSpine Holdings ...	HENNEMAN JOHN B III	Director	Option Exercise	A	17.18	3,858	66,280	3,858
Oct 05 2015	NLNK	NEWLINK GENETICS C ...	HENNEMAN JOHN B III	EVP, Chief Financia ...	Payment of Exercise	F	35.32	4,199	148,309	46,290	50.5 K to 46.3 K (-8.32 %)
Aug 04 2015	SPNE	SeaSpine Holdings ...	HENNEMAN JOHN B III	Director	Option Exercise	A	15.68	58,559	918,205	58,559
May 14 2015	NLNK	NEWLINK GENETICS C ...	HENNEMAN JOHN B III	EVP, Chief Financia ...	Buy	P	37.30	3,000	111,900	50,489	47.5 K to 50.5 K (+6.32 %)
May 14 2015	NLNK	NEWLINK GENETICS C ...	HENNEMAN JOHN B III	EVP, Chief Financia ...	Gift	G	0.00	300	0	47,489	47.8 K to 47.5 K (-0.63 %)

Page: 1